-
2281
Unraveling metabolic signatures in SARS-CoV-2 variant infections using multiomics analysis
Published 2024-12-01Get full text
Article -
2282
-
2283
-
2284
E3 ubiquitin ligase SYVN1 as a promising therapeutic target for diverse human diseases
Published 2025-02-01Get full text
Article -
2285
-
2286
-
2287
-
2288
-
2289
-
2290
-
2291
-
2292
Questionnaire to Survey Cosmetic Outcomes in Laparoscopic Surgery for Colorectal Cancer
Published 2024-09-01Get full text
Article -
2293
-
2294
ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Recept...
Published 2025-01-01“…Naohisa Chiba,1 Toshi Menju,1 Yumeta Shimazu,1 Toshiya Toyazaki,1 Ryota Sumitomo,1 Hideaki Miyamoto,1 Shigeyuki Tamari,1,2 Shigeto Nishikawa,1 Hiroshi Date1 1Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 2Department of Thoracic Surgery, Shizuoka City Shizuoka Hospital, Shizuoka, JapanCorrespondence: Toshi Menju, Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shigoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan, Tel +81-757514975, Email toshimnj@kuhp.kyoto-u.ac.jpBackground: Signaling pathways centered on the G-protein ADP-ribosylation factor 6 (Arf6) and its downstream effector ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 (AMAP1) drive cancer invasion, metastasis, and therapy resistance. …”
Get full text
Article -
2295
-
2296
-
2297
-
2298
-
2299
-
2300
Determinants maintaining healthcare personnel’s motivation during COVID-19 pandemic in Uganda
Published 2025-01-01Get full text
Article